![Paola Pozzo](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Ursprung des Netzwerks ersten Grades von Paola Pozzo
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Luxfold S.A.
![]() Luxfold S.A. BiotechnologyHealth Technology Luxfold S.A. designs and engineers protein structures. It offers protein three-dimensional structure. The company is headquartered in Luxembourg.
2
| Private Company | Biotechnology | 2 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Paola Pozzo
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
NEOVACS | Pharmaceuticals: Major | President | |
Tc Land Expression SA
![]() Tc Land Expression SA Miscellaneous Commercial ServicesCommercial Services Tc Land Expression SA operates as a molecular diagnostic company. It focuses on the development and commercialisation of tests aimed at monitoring patients with immunological conditions. The firm specializes in the area of organ transplantation and immune mediated disorders. Its development programs encompass RA-INF-Dx, IMD Dx2, IMD Dx3, and L-TolX. The company was founded by Marina Guillet and Alain Huriez in November 2002 and is headquartered in Huningue, France. | Miscellaneous Commercial Services | Founder | |
Advent Venture Partners LLP
![]() Advent Venture Partners LLP Investment ManagersFinance Advent Venture Partners LLP (AVP) is a private equity/venture capital firm founded in 1981 by David James Scott Cooksey. The firm is headquartered in London, United Kingdom. | Investment Managers | Private Equity Investor | |
Orphalan SA
![]() Orphalan SA Pharmaceuticals: MajorHealth Technology GMP-Orphan SA engages in the research and development in biotechnology. It focuses on developing and designing drugs for life-threatening and rare diseases. The company was founded by Frederic Marin on July 18, 2011 and is headquartered in Paris, France. | Pharmaceuticals: Major | Chairman | |
AdBio Partners SAS
![]() AdBio Partners SAS Investment ManagersFinance AdBio Partners SAS (AdBio Partners) is a venture capital firm founded in 2015. The firm is headquartered in Paris, France. | Investment Managers | Founder | |
Alderaan Biotechnology SAS
![]() Alderaan Biotechnology SAS BiotechnologyHealth Technology Alderaan Biotechnology SAS operates as preclinical stage firm, that develops monoclonal antibodies for the treatment of cancer. The company was founded by Daniel Olive and Armand Bensussan on July 17, 2017 and is headquartered in Paris, France. | Biotechnology | Director/Board Member | |
Urania Therapeutics SAS
![]() Urania Therapeutics SAS BiotechnologyHealth Technology Urania Therapeutics SAS develops therapeutic solutions for the treatment of genetic diseases caused by pathogenic nonsense mutations. The company was founded by Jean-Paul Renaud, Marat Yusupova, and Gulnara Yusupova in October 2015 and is headquartered in Illkirc, France. | Biotechnology | Chairman | |
Augustine Therapeutics NV
![]() Augustine Therapeutics NV Medical/Nursing ServicesHealth Services Augustine Therapeutics NV is a Belgian company that focuses on developing innovative therapies for neuromuscular and neurodegenerative diseases. The company is based in Leuven, Belgium. The company's main focus is on HDAC6, a class II histone deacetylase, which is a well-known molecular target in various diseases, particularly neurodegenerative disorders and neuropathies. The company was founded in 2019, and Sylvain Celanire has been the CEO of the company since 2020. | Medical/Nursing Services | Director/Board Member | |
DiogenX SAS
![]() DiogenX SAS BiotechnologyHealth Technology DiogenX SAS engages in the discovery and development of biologics therapeutics options of Diabetic patients. It operates in Diabetes preclinical stage business segment. The company was founded by Benjamin Charles, Patrick Collombat and Jean Pascal Tranié on December 24, 2019 and is headquartered in Marseille, France. | Biotechnology | Director/Board Member | |
Tridek-One Therapeutics SAS
![]() Tridek-One Therapeutics SAS Miscellaneous Commercial ServicesCommercial Services Tridek-One Therapeutics SAS is a French private biotechnology company founded in 2018. The company is based in Paris, France. Tridek-One's scientific founders at INSERM conducted groundbreaking research on the role of CD31 in the modulation of the immune response, which forms the basis of the company's work. The company was founded in 2019 by Giuseppina Caligiuri, Antonino Nicoletti, and the CEO is Laurence de Schoulepnikoff. | Miscellaneous Commercial Services | Director/Board Member | |
ITTM SA
![]() ITTM SA Data Processing ServicesTechnology Services ITTM SA provides data integration and knowledge management solutions to bio-medical research areas. Its solutions include data curation, transmart hosting, software development, and data archiving and backup. The company is headquartered in Esch-sur-Alzette, Luxembourg. | Data Processing Services | Chairman |
Statistik
International
Frankreich | 10 |
Vereinigtes Königreich | 2 |
Belgien | 2 |
Luxemburg | 2 |
Sektoral
Health Technology | 6 |
Commercial Services | 3 |
Finance | 3 |
Consumer Services | 2 |
Health Services | 2 |
Operativ
Chairman | 5 |
Founder | 4 |
Director/Board Member | 4 |
President | 3 |
Private Equity Investor | 2 |
Am stärksten vernetzte Beziehungen
Insiders | |
---|---|
Alain Huriez | 12 |
Reinhard Schneider | 2 |
- Börse
- Insiders
- Paola Pozzo
- Unternehmensverbindungen